New Mexico Department of Health · Title 7, Chapter 35 NMAC

The parts of 7.35 NMAC

Each Part of Chapter 35 is one rule. This site holds each published Part, its record, and what it requires of the people it reaches. The statute the rules implement is the Medical Psilocybin Act, Sections 26-2D-1 through 26-2D-11 NMSA 1978: section by section, with the Part that carries each.

Published parts

7.35.2Producer and Laboratory Requirements. Adopted, effective June 23, 2026, published in the New Mexico Register, Volume XXXVII, Issue 12. Proposed amendments to 7.35.2.7, 7.35.2.10, and 7.35.2.24 were published August 25, 2026 and go to the rule hearing on October 2, 2026.Where things stand · The adopted rule · For producers · For testing laboratories · Meetings and filings · Comment

7.35.3Patient enrollment, certifying clinicians, practitioners, facilitators, healing centers and other approved locations, and educational programs. Proposed. The revised proposed rule was published August 25, 2026 and goes to the rule hearing on October 2, 2026.Where things stand · The published rule · Routes to a permit · Meetings and filings · Comment

Not published

No other Part of Chapter 35 has been published. The Medical Psilocybin Act directs the department to establish qualifying conditions, training, treatment protocols, safety protocols, best practices, and data collection (Section 26-2D-7 NMSA 1978), and to promulgate rules for the collection of data from producers, clinicians, and qualified patients for an annual assessment of the program (Section 26-2D-9 NMSA 1978). No published Part carries the assessment reporting of Section 26-2D-9.

About this site

An independent community record of the rulemaking, not affiliated with the New Mexico Department of Health. Every statement rests on a document a member of the public can obtain; the method, the sources, and the corrections path are on How this site is built.